Inventor
TEMPEST PAUL
US30 patents
⚠️ This page may combine multiple inventors who share the name “TEMPEST PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
15 patentsUS8686020B2Apr 1, 2014
Spirocyclic compounds
MERCK SHARP & DOHME17 citations91
US8349825B2Jan 8, 2013
Spirocyclic compounds
MERCK SHARP & DOHME18 citations91
US7834026B2Nov 16, 2010
Spirocyclic compounds
MERCK SHARP & DOHME17 citations91
US8026260B2Sep 27, 2011
Histone deacetylase inhibitors with aryl-pyrazolyl-motifs
MERCK SHARP & DOHME9 citations83
US10822338B2Nov 3, 2020
Substituted aminoquinazoline compounds as A2A antagonist
MERCK SHARP & DOHME2 citations71
US10011615B2Jul 3, 2018
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
MERCK SHARP & DOHME3 citations71
US8367706B2Feb 5, 2013
Inhibitors of janus kinases
MERCK SHARP & DOHME5 citations68
US9676780B2Jun 13, 2017
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
MERCK SHARP & DOHME2 citations61
US9688654B2Jun 27, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations51
US9416126B2Aug 16, 2016
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME2 citations51
US11655216B2May 23, 2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US10961215B2Mar 30, 2021
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations49
US9493440B2Nov 15, 2016
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME2 citations49
US11046714B2Jun 29, 2021
2,2-difluorodioxolo A2A receptor antagonists
MERCK SHARP & DOHME0 citations48
US10894775B2Jan 19, 2021
Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
MERCK SHARP & DOHME0 citations48
APRINOIA THERAPEUTICS LTD
3 patentsUS12377152B2Aug 5, 2025
Compounds for degrading alpha-synuclein aggregates and uses thereof
APRINOIA THERAPEUTICS LTD0 citations57
US11642413B2May 9, 2023
Compounds for degrading Tau protein aggregates and uses thereof
APRINOIA THERAPEUTICS LTD0 citations57
US11291732B1Apr 5, 2022
Compounds for degrading α-synuclein aggregates and uses thereof
APRINOIA THERAPEUTICS LTD1 citations57